Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rod-derived Cone Viability Factor (RdCVF)
- Target
- RdCVF
- Molecular classification
- Thioredoxin-like proteins, Trophic Factor, Secreted Protein
01
Overview
Rod-derived Cone Viability Factor (RdCVF) is a protein secreted by rod photoreceptors in the retina. Encoded by the *NXNL1* gene, it is a truncated thioredoxin that promotes the survival and function of cone photoreceptor cells, particularly under degenerative conditions such as retinitis pigmentosa (RP). RdCVF binds to Basigin-1 (BSG1) on cones, increasing glucose uptake and stimulating aerobic glycolysis. Loss of RdCVF due to rod degeneration contributes to secondary cone death in RP, making it a therapeutic target.
02
Mechanism of action
Enhances glucose uptake and aerobic glycolysis in cone photoreceptors via interaction with Basigin-1 (BSG1)
03
Biological functions
Cone photoreceptor survivalGlucose metabolism regulation in conesNeuroprotection
04
Disease associations
Retinitis pigmentosaRetinal degeneration
05
Safety considerations
Potential for off-target effectsChallenges in large-scale production and purificationDelivery method optimization (gene therapy vs. protein injection)
Beyond the preview
Go deeper on Rod-derived Cone Viability Factor (RdCVF).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rod-derived Cone Viability Factor (RdCVF).